News Search Results
Jun 10, 2025, 09:00 ET Insilico Medicine Launches Nach01 Foundation Model on AWS Marketplace to Help Accelerate Generative Chemistry Innovation
10, 2025 /PRNewswire/ -- Insilico Medicine, a clinical-stage biotechnology company driven by generative artificial intelligence (AI), today announced the recent release of its Nach01 foundation model on Amazon Web Services
More news about: Insilico Medicine
Jun 10, 2025, 09:00 ET Hemab Therapeutics to Present Clinical and Preclinical Data from Multiple Bleeding Disorder Programs at the ISTH 2025 Congress
Mass., June 10, 2025 /PRNewswire/ -- Hemab Therapeutics, a clinical-stage biotechnology company developing novel prophylactic therapeutics for serious, underserved bleeding and thrombotic disorders, today announced a total of 11 presentations
More news about: Hemab Therapeutics
Jun 10, 2025, 08:59 ET Spiderwort Biotechnologies Inc. Receives Health Canada Investigational Testing Authorization for Next-Generation Dermal Filler
ON, June 10, 2025 /PRNewswire/ - Spiderwort Biotechnologies Inc., a pioneering biotechnology company focused on cellulose-based regenerative medicine, today announced it has received Investigational Testing Authorization (ITA) from Health
More news about: Spiderwort Biotechnologies Inc.
Jun 10, 2025, 08:58 ET X-Therma Welcomes Biotech Veteran Neil Warma to its Board of Directors
X-Therma Inc., a pioneering biotechnology company focused on revolutionizing regenerative medicine through its innovative biopreservation platform, today announced the appointment of
More news about: X-Therma.com
Jun 10, 2025, 08:37 ET Nordic Capital to partner with Minerva Imaging, to support its growth journey in the radiopharmaceutical space
that combines scientific excellence with end-to-end service capabilities. The company partners with many of the world's leading pharmaceutical and biotechnology companies and is widely recognised for its industry-leading expertise and best-in-class capabilities. Today, Minerva employs over 150 highly skilled
More news about: Nordic Capital
Jun 10, 2025, 08:31 ET Nordic Capital to partner with Minerva Imaging, to support its growth journey in the radiopharmaceutical space
that combines scientific excellence with end-to-end service capabilities. The company partners with many of the world's leading pharmaceutical and biotechnology companies and is widely recognised for its industry-leading expertise and best-in-class capabilities. Today, Minerva employs over 150 highly skilled
More news about: Nordic Capital
Jun 10, 2025, 08:00 ET ImmVira Announces First Patient Dosed in a Multi-Regional Phase II Clinical Trial Evaluating MVR-T3011 Oncolytic Immunotherapy in Patients with BCG-Unresponsive High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC)
China, June 10, 2025 /PRNewswire/ -- ImmVira, a global leading clinical-stage biotechnology company focused on the development of next-generation novel oncolytic immunotherapy for treatment of cancer, announced that the first patient diagnosed
More news about: ImmVira
Jun 10, 2025, 07:50 ET ZINZINO AB (PUBL.): Zinzino acquires assets from Ecosystem for increased distribution power in France and DOM-TOM
another strategically important step in Zinzino's growth plans focused on improving personal health and well-being on a global scale with innovative biotechnology and a pioneering product portfolio marketed through direct sales. Ecosystem is a French direct selling company based in Paris
More news about: Zinzino
Jun 10, 2025, 07:40 ET OS Therapies Partners with EVERSANA for the U.S. Commercialization of OST-HER2 in Recurrent, Fully Resected, Pediatric Lung Metastatic Osteosarcoma
OS Therapies Inc. (NYSE-A: OSTX) ("OS Therapies" or "the Company"), a clinical-stage cancer immunotherapy and antibody drug conjugate biotechnology company, has selected
More news about: EVERSANA
Jun 10, 2025, 07:30 ET Factor Bioscience to Unveil iMacrophages Engineered to Combat Solid Tumors at the ISSCR Annual Meeting
June 10, 2025 /PRNewswire/ -- Factor Bioscience Inc., a Cambridge-based biotechnology company focused on using its pioneering gene editing platform to develop life-saving cell and gene therapies, today announced its participation
More news about: Factor Bioscience Inc.
Jun 10, 2025, 07:00 ET Anixa Biosciences' Breast Cancer Vaccine Receives National News Coverage
Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that its CEO, Dr. Amit Kumar, was interviewed
More news about: Anixa Biosciences, Inc.
Jun 10, 2025, 07:00 ET Adcendo ApS Announces First Patient Dosed in Phase I/II ADCElerate1 Trial of ADCE-D01
first-in-class pan-mesenchymal cancer targeting ADC in phase 1/2 clinical development. About Adcendo Adcendo is a clinical-stage biotechnology company headquartered in Copenhagen, Denmark, with operations in Boston, Massachusetts.
More news about: Adcendo
Jun 10, 2025, 07:00 ET Adcendo ApS Announces First Patient Dosed in Phase I/II ADCElerate1 Trial of ADCE-D01
first-in-class pan-mesenchymal cancer targeting ADC in phase 1/2 clinical development. About Adcendo Adcendo is a clinical-stage biotechnology company headquartered in Copenhagen, Denmark, with operations in Boston, Massachusetts.
More news about: Adcendo
Jun 10, 2025, 07:00 ET ScaleReady Announces a G-Rex® Grant has been awarded to Immuneel Therapeutics
G-Rex® process at a time. About Immuneel therapeutics Private LimitedImmuneel Therapeutics Private Limited is a cutting-edge biotechnology company based in Bangalore, India, at the forefront of advancing cell and gene therapies, as well as personalized
More news about: Bio-Techne Corporation
Jun 10, 2025, 06:00 ET Sanyou Biopharmaceuticals and Medicovestor, Inc. Forge Strategic Partnership to Develop First-in-Class Chemoimmunotherapy Antibody-Drug Conjugates
R&D today announced the signing of a strategic cooperation agreement with Medicovestor, Inc., a New York-based biotechnology company pioneering first-in-class chemoimmunotherapy antibody-drug conjugates (ADCs). The agreement, officially
More news about: Sanyou Bio
Jun 10, 2025, 06:00 ET Blue Water Acquisition Corp. III Announces the Upsized Pricing of $220 Million Initial Public Offering
business, industry, sector or geographical location, the Company intends to focus on high-potential companies in the artificial intelligence (AI), biotechnology, healthcare and technology sectors. Forward-Looking Statements This press release contains statements that constitute "forward-looking
More news about: Blue Water Acquisition Corp iii
Jun 10, 2025, 04:49 ET Nuevocor Announces FDA Clearance of IND for NVC-001 for LMNA-Related Dilated Cardiomyopathy
-- Nuevocor, a Singapore-headquartered biotechnology company developing cures for cardiomyopathies driven by aberrant mechanobiology, today announced that the U.S. Food and Drug Administration (FDA)
More news about: Nuevocor
Jun 10, 2025, 04:15 ET Caliway to Present First Preclinical Data on CBL-514 for GLP-1 Weight Rebound Management at BIO 2025
enhancing the overall treatment impact and long-term value." The BIO International Convention is the world's largest and most influential biotechnology event, attracting over 20,000 professionals and 5,000 companies from 80+ countries. It serves as a global platform for business development, innovation
More news about: Caliway Biopharmaceuticals
Jun 10, 2025, 03:00 ET AMSilk enters Consumer Care Market with the launch of AMSilk4Shine and AMSilk4Care
commented: "With AMSilk4Shine and AMSilk4Care, we are pushing the boundaries of bio-based consumer care solutions by offering an affordable biotechnology ingredient that meets the growing demand for eco-conscious products – without compromising on performance. This marks an exciting step forward for
More news about: AMSilk
Jun 09, 2025, 15:12 ET ADAR1 Issues Statement on Keros Therapeutics' Troubling 2025 Director Election Results and Insufficient Capital Return Proposal
investment manager based in Austin, Texas, focused on public and private equity investments in the life sciences and biotechnology sectors. The firm was founded in October 2018 by Dr. Daniel Schneeberger, who brings
More news about: ADAR1 Capital Management, LLC
Jun 09, 2025, 14:00 ET Myosin Therapeutics Receives FDA Clearance to Initiate First-in-Human Trial of MT-125 in Glioblastoma
Fla., June 9, 2025 /PRNewswire/ -- Myosin Therapeutics, Inc., a clinical-stage biotechnology company developing first-in-class therapies targeting molecular motors, today announced that the U.S. Food and Drug Administration (FDA) has accepted
More news about: Myosin Therapeutics Inc.
Jun 09, 2025, 12:45 ET Formation Bio Announces First Class of Entrepreneurs in Residence to Drive Pipeline Growth and Strategic Partnerships
business development at Synageva Biopharma and Javelin Pharmaceuticals and helped launch the Entrepreneur in Residence program at the North Carolina Biotechnology Center. Over his career, John has executed more than $1 billion in transactions—including regional partnerships at
More news about: Formation Bio
Jun 09, 2025, 12:22 ET Rubin and Rudman's John McGivney Named a 2025 Top 20 Managing Partner by Massachusetts Lawyers Weekly
Rubin and Rudman serves national and international companies, including large public companies and closely held businesses; real estate developers; biotechnology, pharmaceutical and medical device makers; regulated industries, public entities and municipalities; insurance companies and their insureds; educational
More news about: Rubin and Rudman
Jun 09, 2025, 10:00 ET tcmc to Showcase Asia's Leading Cell & Gene Therapy CDMO Capabilities at BIO International Convention
Convention, June 16-19. Often referred to as the 'TSMC of the CGT industry,' tcmc's presence at this premier global biotechnology event underscores its pivotal role in driving CGT innovation from Asia to the world.
More news about: tcmc
Jun 09, 2025, 09:00 ET Sequentify and Bio Molecular Systems Partner to Release InfiniSeq™ Myra Protocol for Automated NGS Library Preparation
https://www.sequentify.com/. About BMS: Bio Molecular Systems (BMS) is a biotechnology company that designs, manufactures and distributes instrumentation for the life sciences. Established in 2010 and composed of the founders and senior
More news about: Sequentify